Magdalene K. Sgagias

Array ( [id] => 4609796 [patent_doc_number] => 07994298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Chimeric NK receptor and methods for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/575878 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9892 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994298.pdf [firstpage_image] =>[orig_patent_app_number] => 11575878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738056 [patent_doc_number] => 20060008446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Methods for treating pain' [patent_app_type] => utility [patent_app_number] => 11/215721 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 34528 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008446.pdf [firstpage_image] =>[orig_patent_app_number] => 11215721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5847734 [patent_doc_number] => 20060123490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Pluripotent cells with improved efficiency of homologous recombination and use of the same' [patent_app_type] => utility [patent_app_number] => 11/212101 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37107 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20060123490.pdf [firstpage_image] =>[orig_patent_app_number] => 11212101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639720 [patent_doc_number] => 08017747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Apoptosis-inducing genes for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/661224 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20762 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017747.pdf [firstpage_image] =>[orig_patent_app_number] => 11661224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886428 [patent_doc_number] => 20080260760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Prostate-Specific Antigen-Derived Mhc Class H-Restricted Peptides and Their Use in Vaccines to Treat or Prevent Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 11/573667 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16605 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260760.pdf [firstpage_image] =>[orig_patent_app_number] => 11573667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801354 [patent_doc_number] => 20060035857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Methods and compositions for the diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/200527 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28888 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035857.pdf [firstpage_image] =>[orig_patent_app_number] => 11200527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912861 [patent_doc_number] => 20060127923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Internal ribosomal entry site mediated gene expression' [patent_app_type] => utility [patent_app_number] => 11/191806 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16400 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127923.pdf [firstpage_image] =>[orig_patent_app_number] => 11191806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771372 [patent_doc_number] => 20060021075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Group 1 CD1 transgenic mice and their uses' [patent_app_type] => utility [patent_app_number] => 11/181234 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 40913 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20060021075.pdf [firstpage_image] =>[orig_patent_app_number] => 11181234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959760 [patent_doc_number] => 20080274185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Shape and Dimension Maintenance of Soft Tissue Grafts by Stem Cells' [patent_app_type] => utility [patent_app_number] => 11/571180 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274185.pdf [firstpage_image] =>[orig_patent_app_number] => 11571180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930757 [patent_doc_number] => 20050281791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Method for inducing cardiac myocytes in embryonic stem (ES) cells by induction with precardiac endoderm and mesoderm' [patent_app_type] => utility [patent_app_number] => 11/159567 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5571 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281791.pdf [firstpage_image] =>[orig_patent_app_number] => 11159567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514323 [patent_doc_number] => 20090214629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'GENE TRANSFER METHOD' [patent_app_type] => utility [patent_app_number] => 11/915474 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2725 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214629.pdf [firstpage_image] =>[orig_patent_app_number] => 11915474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020056 [patent_doc_number] => 20050222075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Process for delivering nucleic acids to cardiac tissue' [patent_app_type] => utility [patent_app_number] => 11/137317 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222075.pdf [firstpage_image] =>[orig_patent_app_number] => 11137317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699589 [patent_doc_number] => 20060216273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Gene therapy for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/134938 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4424 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216273.pdf [firstpage_image] =>[orig_patent_app_number] => 11134938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019473 [patent_doc_number] => 20050221492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer' [patent_app_type] => utility [patent_app_number] => 11/134674 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13100 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221492.pdf [firstpage_image] =>[orig_patent_app_number] => 11134674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4492405 [patent_doc_number] => 07955846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Compositions comprising female germline stem cells and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/131114 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 45 [patent_no_of_words] => 30357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/955/07955846.pdf [firstpage_image] =>[orig_patent_app_number] => 11131114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112436 [patent_doc_number] => 07718846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Animal models of long QT syndrome and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/130031 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 34328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718846.pdf [firstpage_image] =>[orig_patent_app_number] => 11130031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669325 [patent_doc_number] => 20080044385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Novel Modified Galectin 8 Proteins and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/629296 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35479 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044385.pdf [firstpage_image] =>[orig_patent_app_number] => 11629296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6963038 [patent_doc_number] => 20050216958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Cells of which genome is modified' [patent_app_type] => utility [patent_app_number] => 11/127173 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 50734 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20050216958.pdf [firstpage_image] =>[orig_patent_app_number] => 11127173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812790 [patent_doc_number] => 20080193421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Multicellular Tissue and Organ Culture Systems' [patent_app_type] => utility [patent_app_number] => 11/597317 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8364 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193421.pdf [firstpage_image] =>[orig_patent_app_number] => 11597317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7047274 [patent_doc_number] => 20050251869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Animal model for raising HDL-cholesterol with niacin' [patent_app_type] => utility [patent_app_number] => 11/121811 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20050251869.pdf [firstpage_image] =>[orig_patent_app_number] => 11121811 [rel_patent_id] =>[rel_patent_doc_number] =>)